WilmerHale Advises Phantom Neuro in $6M Expanded Seed Financing

Download IconDownload Print IconPrint

WilmerHale Advises Phantom Neuro in $6M Expanded Seed Financing

Client News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.
Critical industry insight and formidable strength across key practices.

On September 12, 2022, Phantom Neuro, a first-of-its-kind neurotech startup specializing in robotic orthopedic technologies, announced that it secured $6 million in its second round of funding. The round, which was led by new investor Time BioVentures, brings the company’s total funding to $9.5 million and included participation from returning investors LionBird Ventures, Draper Associates and Breakout Ventures. Phantom Neuro intends to utilize the new funds to advance its mission of enabling lifelike control of robotic orthopedic technologies like prosthetic limbs and exoskeletons.

The WilmerHale team advising Phantom Neuro was led by Adam Freiman and Brendan Catalano.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel